NO177270C - Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren - Google Patents

Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren

Info

Publication number
NO177270C
NO177270C NO865191A NO865191A NO177270C NO 177270 C NO177270 C NO 177270C NO 865191 A NO865191 A NO 865191A NO 865191 A NO865191 A NO 865191A NO 177270 C NO177270 C NO 177270C
Authority
NO
Norway
Prior art keywords
csf
colony
stimulating
meth
expressing
Prior art date
Application number
NO865191A
Other languages
English (en)
Norwegian (no)
Other versions
NO177270B (no
NO865191L (no
NO865191D0 (no
Inventor
Paul Habermann
Hubert Mullner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO865191D0 publication Critical patent/NO865191D0/no
Publication of NO865191L publication Critical patent/NO865191L/no
Publication of NO177270B publication Critical patent/NO177270B/no
Publication of NO177270C publication Critical patent/NO177270C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO865191A 1985-12-21 1986-12-19 Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren NO177270C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853545568 DE3545568A1 (de) 1985-12-21 1985-12-21 Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung

Publications (4)

Publication Number Publication Date
NO865191D0 NO865191D0 (no) 1986-12-19
NO865191L NO865191L (no) 1987-06-22
NO177270B NO177270B (no) 1995-05-08
NO177270C true NO177270C (no) 1995-08-16

Family

ID=6289242

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865191A NO177270C (no) 1985-12-21 1986-12-19 Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren

Country Status (17)

Country Link
EP (1) EP0228018B1 (da)
JP (1) JP2575367B2 (da)
KR (1) KR940005585B1 (da)
AT (1) ATE71144T1 (da)
AU (2) AU601959B2 (da)
CA (1) CA1341197C (da)
DE (2) DE3545568A1 (da)
DK (1) DK170346B1 (da)
ES (1) ES2055686T3 (da)
FI (1) FI91168C (da)
GR (1) GR3003999T3 (da)
HU (1) HU202584B (da)
IE (1) IE59779B1 (da)
IL (1) IL81020A (da)
NO (1) NO177270C (da)
PT (1) PT83972B (da)
ZA (1) ZA869557B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
EP0238655A4 (en) * 1985-10-03 1989-09-11 Biogen Nv POLYPEPTIDES LIKE THE GRANULOCYTE-MACROPHOUS COLONY STIMULATION FACTORS (GM-CSF) AND THEIR METHODS OF PRODUCING LARGE QUANTITIES IN MICROBIAL CELLS.
DE3712985A1 (de) * 1987-04-16 1988-11-03 Hoechst Ag Bifunktionelle proteine
US5359035A (en) * 1985-12-21 1994-10-25 Hoechst Aktiengesellschaft Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
JPS6420097A (en) * 1987-03-02 1989-01-24 Sumitomo Chemical Co Human granulocyte-macrophage colony stimulating factor
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
WO1988010310A1 (en) * 1987-06-25 1988-12-29 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
EP0318184A1 (en) * 1987-11-12 1989-05-31 Schering Corporation Acceleration of bone formation with GM-CSF
GB2212159B (en) * 1987-11-13 1992-01-22 British Bio Technology Synthetic gene for human granulocyte/macrophage colony stimulating factor.
WO1989010403A1 (en) * 1988-04-21 1989-11-02 Medvet Science Pty. Ltd. Human gm-csf variants
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
JP3115318B2 (ja) * 1989-08-22 2000-12-04 イミュネックス・コーポレーション Ｇｍ―ｃｓｆ及びｉｌ―３を含む融合タンパク質
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
WO1997012054A1 (fr) * 1995-09-28 1997-04-03 Otsuka Pharmaceutical Co., Ltd. Lymphokine chemotactique neutrophile, medicament et necessaire de diagnostic de la granulopenie hypersensible aux medicaments la contenant
RU2144083C1 (ru) * 1998-03-13 2000-01-10 Государственный научный центр вирусологии и биотехнологии "Вектор" Способ промышленного получения рекомбинантного гранулоцит-макрофаг-колониестимулирующего фактора человека
KR100448021B1 (ko) * 2001-12-28 2004-09-08 크레아젠 주식회사 마우스 과립구 대식세포 콜로니 촉진인자 발현벡터 ｐＧＭ-ＣＳＦ로 형질전환된 대장균 및 상기 마우스 과립구 대식세포 콜로니 촉진인자의 대량생산방법
US9157084B2 (en) 2009-12-23 2015-10-13 Gradalis, Inc. Furin-knockdown bi-functional RNA
EP2515916B1 (en) * 2009-12-23 2016-03-09 Gradalis, Inc. Furin-knockdown and gm-csf-augmented (fang) cancer vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
NZ212645A (en) * 1984-07-06 1990-02-26 Sandoz Ltd Method for producing primate granulocyte-macrophage colony stimulating factor (gm-csf)
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
EP0202300B1 (en) * 1984-11-20 1992-11-11 Schering Biotech Corporation Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
EP0238655A4 (en) * 1985-10-03 1989-09-11 Biogen Nv POLYPEPTIDES LIKE THE GRANULOCYTE-MACROPHOUS COLONY STIMULATION FACTORS (GM-CSF) AND THEIR METHODS OF PRODUCING LARGE QUANTITIES IN MICROBIAL CELLS.
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
DE3636903A1 (de) * 1985-12-21 1987-07-02 Hoechst Ag Fusionsproteine mit eukaryotischem ballastanteil

Also Published As

Publication number Publication date
NO177270B (no) 1995-05-08
HUT44615A (en) 1988-03-28
FI865186A0 (fi) 1986-12-18
ES2055686T3 (es) 1994-09-01
KR870006188A (ko) 1987-07-09
KR940005585B1 (ko) 1994-06-21
FI91168C (fi) 1994-05-25
PT83972A (de) 1987-01-01
ZA869557B (en) 1987-10-28
IE59779B1 (en) 1994-04-06
GR3003999T3 (da) 1993-03-16
AU6675686A (en) 1987-06-25
DK170346B1 (da) 1995-08-07
JP2575367B2 (ja) 1997-01-22
FI865186L (fi) 1987-06-22
PT83972B (pt) 1989-07-31
IL81020A (en) 1995-11-27
IL81020A0 (en) 1987-03-31
HU202584B (en) 1991-03-28
CA1341197C (en) 2001-03-06
AU6268390A (en) 1990-12-13
AU601959B2 (en) 1990-09-27
EP0228018A2 (de) 1987-07-08
NO865191L (no) 1987-06-22
DE3545568A1 (de) 1987-07-16
DE3683267D1 (de) 1992-02-13
DK619086D0 (da) 1986-12-19
FI91168B (fi) 1994-02-15
NO865191D0 (no) 1986-12-19
ATE71144T1 (de) 1992-01-15
EP0228018B1 (de) 1992-01-02
DK619086A (da) 1987-06-22
JPS62164695A (ja) 1987-07-21
AU637139B2 (en) 1993-05-20
IE863335L (en) 1987-06-21
EP0228018A3 (en) 1987-12-02

Similar Documents

Publication Publication Date Title
AU637139B2 (en) Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
DE3650538D1 (de) Interleukin-4 protein mit bcgf- und tcgf-aktivität gegenüber menschlichen zellen (menschliches interleukin-4)
NO914387L (no) Fremstilling av hemoglobin og dens analoger i bakterier og gjaer
DE3680613D1 (de) Menschlicher granuloxcyt-kolonie-stimulierungsfaktor.
CA2033176A1 (en) Growth hormone fusion proteins
CA2066618A1 (en) Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells
DK282887D0 (da) Humane granulocyt-makrofag-kolonistimulationsfaktor-lignende polypeptider og fremgangsmaader til fremstilling deraf i hoeje udbytter i mikrobielle celler
PT80300A (de) Herstellung von polypeptiden mit human-gammainterferonaktivitat
ATE132900T1 (de) Gene, die ein protein mit menschlicher macif- aktivität kodieren, expressionsvektoren mit diesen genen, transformantenzellen und proteine mit menschlicher macif-aktivität
JPS6480298A (en) Production of human proapolipoprotein a-i-like protein
ATE66611T1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.